Mutational Testing

/Tag: Mutational Testing

Personalized Medicine – Another Look

The issue of personalized medicine, also referred to as "precision medicine" in the article, was addressed in a newsletter article by LRG Executive Director Norman Scherzer in February. We hope to follow up with more articles on the topic soon.

By |2014-09-14T11:30:48-04:00April 22nd, 2013|Advocacy, Mutational Testing, News|

LRG & colleagues make their mark on 17th annual CTOS meeting in Prague

Representatives from the Life Raft Group recently traveled to Prague, Czech Republic to attend the annual Connective Tissue Oncology Society (CTOS) meeting. CTOS is an international group comprised of physicians and scientists with a primary interest in the tumors of connective tissues.

By |2014-09-14T11:31:32-04:00February 1st, 2013|Events, News|

Mutation Types

Learn about various mutation types. There are several types of gene mutations that can lead to Gastrointestinal Stromal Tumors. These include KIT mutations, PDGFRA mutations and BRAF and SDH mutations. As each of these involves [...]

By |2014-09-14T11:32:30-04:00September 20th, 2012|GIST Education|

State of the GIST Community Part 3: What do we know about mutational testing?

As of May 1, 2011, the LRG patient registry only received 377 reports of mutations out of 1,327 patients, which only represents 28 percent of the entire registry. Part of this may be related to the fact that mutational testing is not common practice at diagnosis.

By |2019-04-05T09:20:33-04:00June 1st, 2011|Mutational Testing, News|

Mutational Testing & Survival: Where We Stand

Only six percent of GIST patients in the United States take advantage of testing that could be used to individualize their treatment according to a new article in the Annals of Oncology. Dr. Peter Pisters of MD Anderson Cancer Center in Houston, Texas and his colleagues reported results of the GIST reGISTry, a Novartis Pharmaceuticals-supported registry of 882 GIST patients in the United States.

By |2019-04-05T09:52:42-04:00June 1st, 2011|Mutational Testing, News, Survival Strategies|

LRG Webcast: Mutational Testing Broken Down

Join Dr. Michael Heinrich and Dr. Christopher Corless as they demystify mutational analysis. Dr. Heinrich and Dr. Corless and their labs at Oregon Health and Science University are pioneers in mutational analysis for GIST and other cancers

By |2019-04-05T10:11:53-04:00September 25th, 2009|Mutational Testing, News, Webcast|

Recent Posts

Upcoming Events

  1. Kathy Sarmiento Medicare 101 Webcast

    LRG Webcast Series: Medicare 101

    September 9 @ 12:00 PM - 1:00 PM
  2. GDOL Ottawa logo

    GIST Day of Learning – Ottawa

    September 28 @ 9:00 AM - 4:30 PM